Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of LRP1+CD13+ human periosteal stem cells that require LRP1 for bone repair
Youngjae Jeong, Lorenzo Deveza, Laura Ortinau, Kevin Lei, John R. Dawson, Dongsu Park
Youngjae Jeong, Lorenzo Deveza, Laura Ortinau, Kevin Lei, John R. Dawson, Dongsu Park
View: Text | PDF
Research Article Bone biology Stem cells

Identification of LRP1+CD13+ human periosteal stem cells that require LRP1 for bone repair

  • Text
  • PDF
Abstract

Human periosteal skeletal stem cells (P-SSCs) are critical for cortical bone maintenance and repair. However, their in vivo identity, molecular characteristics, and specific markers remain unknown. Here, single-cell sequencing revealed human periosteum contains SSC clusters expressing known SSC markers, podoplanin (PDPN) and PDGFRA. Notably, human P-SSCs, but not bone marrow SSCs, selectively expressed identified markers low density lipoprotein receptor-related protein 1 (LRP1) and CD13. These LRP1+CD13+ human P-SSCs were perivascular cells with high osteochondrogenic but minimal adipogenic potential. Upon transplantation into bone injuries in mice, they preserved self-renewal capability in vivo. Single-cell analysis of mouse periosteum further supported the preferential expression of LRP1 and CD13 in Prx1+ P-SSCs. When Lrp1 was conditionally deleted in Prx1 lineage cells, it led to severe bone deformity, short stature, and periosteal defects. By contrast, local treatment with an LRP1 agonist at the injury sites induced early P-SSC proliferation and bone healing. Thus, human and mouse periosteum contains unique osteochondrogenic stem cell subsets, and these P-SSCs express specific markers, LRP1 and CD13, with a regulatory mechanism through LRP1 that enhances P-SSC function and bone repair.

Authors

Youngjae Jeong, Lorenzo Deveza, Laura Ortinau, Kevin Lei, John R. Dawson, Dongsu Park

×

Figure 8

Mouse Prx1+ P-SSCs selectively express LRP1.

Options: View larger image (or click on image) Download as PowerPoint
Mouse Prx1+ P-SSCs selectively express LRP1.
(A) UMAP visualization of 9...
(A) UMAP visualization of 9 different color-coded clusters, including Prx1+ P-SSCs (clusters 1 and 2) and other osteochondrogenic, smooth muscle cell clusters in long bone periosteal tissues in the mouse. (B) UMAP-based transcriptional plots of PRRX1, LRP1, CD13, osteogenic (Runx2 & Bglap), and chondrogenic (Col2a1) markers. (C–F) Representative immunofluorescence staining images of the indicated markers (Prx1-GFP, CD13 [Alexa-594], and LRP1 [Alexa-633]; GFP+CD13+LRP1+ cells: orange arrow; GFP+CD13+LRP1− cells: yellow arrowhead) of femoral sections (10x). (G) FACS analysis of surface expression of Prx1-GFP in LRP1+CD13+PDGFRA+ and LRP1−CD13+PDGFRA+ periosteal cells. Data presented as mean ± SD. **P < 0.01 by 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts